Neurodon, LLC
PrivateLast Round
Grant
Oct 3, 2023
Total Funding Raised
$6.16M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neurodon, LLC is a biopharmaceutical company that develops disease-modifying small molecule therapeutics targeting cellular stress and calcium imbalance for the treatment of diabetes, neurodegeneration, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurodon, LLC Comparables
Compare Neurodon, LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OptiKira, LLC | 77% | |
| ER Stress Research Institute, Inc. | 76% | |
| AstronauTx | 68% |
Neurodon, LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 3, 2023 | ||||
| Grant | Jan 3, 2022 | ||||
| Grant | Aug 11, 2020 | ||||
| Grant | Jan 4, 2019 | ||||
| Grant | Sep 24, 2018 |
Neurodon, LLC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elevate Ventures | Grant |
| National Institute on Aging | Grant |
| JDRF | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 105% MoM.
- Jun 18, 2026
Monthly visitors increased 90% MoM.
Neurodon, LLC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurodon, LLC's valuation, stock price, and market status.
Is Neurodon, LLC a public or private company?
Neurodon, LLC is a private company.
What is the current stock price of Neurodon, LLC?
Neurodon, LLC is a private company with no public stock price. Caplight tracks Neurodon, LLC's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Neurodon, LLC worth (valuation)?
Valuation information for Neurodon, LLC is not publicly available.
Can I buy Neurodon, LLC stock?
Neurodon, LLC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurodon, LLC's last funding round?
Neurodon, LLC's most recent funding round was Grant on October 3, 2023.
Who are the main investors in Neurodon, LLC?
Key investors in Neurodon, LLC include Elevate Ventures, National Institute on Aging, JDRF.
Will Neurodon, LLC IPO soon?
No public IPO plans have been announced for Neurodon, LLC.
How can I track Neurodon, LLC secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurodon, LLC's secondary market activity and sign up for updates.